Site Engagement Lead
ICON plc
Summary
ICON plc is a global leader in clinical research and healthcare intelligence, founded in Dublin, Ireland in 1990. As one of the world's largest contract research organizations (CROs), ICON provides comprehensive outsourced development services to pharmaceutical, biotechnology, and medical device companies worldwide. The company operates in 55 countries with approximately 41,900 employees, offering end-to-end solutions that span the entire product development lifecycle. ICON's service portfolio includes clinical research services, adaptive trials, biosimilars, commercialization and outcomes consulting, medical imaging, laboratory services, and strategic support for traditional and digital health technologies. The company specializes in therapeutic areas such as oncology, cardiovascular diseases, central nervous system disorders, rare diseases, and women's health. With its 2021 acquisition of PRA Health Sciences, ICON significantly expanded its capabilities and market position, becoming a dominant force in the global CRO industry. The company is publicly traded on NASDAQ under the ticker ICLR and reported $8.28 billion in revenue for 2024.
Job description
What You Will Do
- Develop and implement site-specific action plans to accelerate patient recruitment and retention
- Educate healthcare professionals and site staff on study protocols, procedures, and disease areas
- Engage with the public in formal health fairs or patient advocacy group events to provide approved, publicly available information
- Partner with referral networks to identify potential trial participants
- Analyze site performance data to tailor recruitment strategies and improve enrollment outcomes
- Conduct recruitment educational sessions and share best practices across sites
- Maintain accurate records in internal reporting systems
- Stay current with technical knowledge in relevant therapeutic areas
Your Profile
- Bachelor's degree in life sciences or a related field
- Minimum 2–3 years of relevant experience working in clinical trials
- 1 year of immunology experience; preferred dermatology
- 1 year of experience as a Clinical Trial Educator/Site Engagement Lead/Clinical Trial Liaison like role
- Deep knowledge and Clinical competence in relevant therapeutic areas
- Strong interpersonal and communication skills
- Ability to work independently and make informed decisions
- Collaborative mindset with a strong customer service orientation
- High flexibility to travel and adapt to diverse cultural environments
- Mentorship capabilities and willingness to take on additional responsibilities
- Proactive, solution-oriented approach with a can-do attitude
Requirements
- Bachelor's degree in life sciences or a related field
- Minimum 2–3 years of relevant experience working in clinical trials
- 1 year of immunology experience; preferred dermatology
- 1 year of experience as a Clinical Trial Educator/Site Engagement Lead/Clinical Trial Liaison like role
- Deep knowledge and Clinical competence in relevant therapeutic areas
- Strong interpersonal and communication skills
- Ability to work independently and make informed decisions
- Collaborative mindset with a strong customer service orientation
- High flexibility to travel and adapt to diverse cultural environments
- Mentorship capabilities and willingness to take on additional responsibilities
- Proactive, solution-oriented approach with a can-do attitude
Benefits
- Competitive base salary
- Performance related incentives
- Medical, Dental & Vision
- Retirement plans
- Pension plans
- Life assurance
- Disability coverage
- Employee assistance programmes
- Wellbeing resources
- Learning and development opportunities
Company overview
ICON plc is a global leader in clinical research and healthcare intelligence, founded in Dublin, Ireland in 1990. As one of the world's largest contract research organizations (CROs), ICON provides comprehensive outsourced development services to pharmaceutical, biotechnology, and medical device companies worldwide. The company operates in 55 countries with approximately 41,900 employees, offering end-to-end solutions that span the entire product development lifecycle. ICON's service portfolio includes clinical research services, adaptive trials, biosimilars, commercialization and outcomes consulting, medical imaging, laboratory services, and strategic support for traditional and digital health technologies. The company specializes in therapeutic areas such as oncology, cardiovascular diseases, central nervous system disorders, rare diseases, and women's health. With its 2021 acquisition of PRA Health Sciences, ICON significantly expanded its capabilities and market position, becoming a dominant force in the global CRO industry. The company is publicly traded on NASDAQ under the ticker ICLR and reported $8.28 billion in revenue for 2024.